Abciximab: benefits for some in ACS

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1535, 2006-01, pp. : 15-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Abciximab disappoints in ACS without early revascularisation

By  

Inpharma, Vol. 1, Iss. 1257, 2000-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Abciximab beneficial in younger patients with ACS undergoing PCI

By  

Inpharma, Vol. 1, Iss. 1569, 2007-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

CD40 levels predict benefit from abciximab in ACS

By  

Inpharma, Vol. 1, Iss. 1380, 2003-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

ACS report: Progress lags in some cancer control efforts

By Printz Carrie  

Cancer, Vol. 121, Iss. 15, 2015-08 ,pp. : 2478-2479

Blackwell Publishing

Access to resources Recommend Favorite

The benefits of abciximab questioned in percutaneous coronary interventions following pretreatment with high-dose clopidogrel

By Salam Amar Mohammad  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 3, 2005-03 ,pp. : 335-338

Informa Healthcare

Access to resources Recommend Favorite